Status:
UNKNOWN
Epidemiological Characteristics and Prediction System of Acute Respiratory Distress Syndrome
Lead Sponsor:
China-Japan Friendship Hospital
Conditions:
Acute Respiratory Distress Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
This project intends to adopt the multicenter prospective real-world study method to conduct a preliminary study on the incidence, grading, risk factors, respiratory support strategies, in-hospital mo...
Eligibility Criteria
Inclusion
- New or worsening respiratory symptoms less than 7 days after the acute blow.
- CT/X-ray: Double lung infiltration that cannot be fully explained by pleural effusion, lobar/whole atelectasis, and nodule.
- Respiratory failure that cannot be explained by heart failure or fluid overload
- After 15min assisted ventilation (PEEP or CPAP ≥ 5cmH2O) or HFNC with flow≥30L/min, PaO2/FiO2≤300mmHg
- Classification of ARDS: mild (200mmHg \< PaO2/FIO2 ≤ 300mmHg), moderate (100mmHg \< PaO2/FIO2 ≤ 200mmHg), and severe (PaO2/FIO2 ≤ 100mmHg) and 4 ancillary variables for severe ARDS
Exclusion
- younger than 18 years old
- Patients or family members refused to participate in the study
Key Trial Info
Start Date :
October 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2025
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06069466
Start Date
October 15 2023
End Date
July 31 2025
Last Update
October 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital
Beijing, Beijing Municipality, China, 100029